Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses

BACKGROUND: Phambili, the Merck (MRK)-Adenovirus Type 5 (Ad5) HIV-1 gag/pol/nef subtype B vaccine study, conducted in South Africa, suspended enrollment and vaccination when companion study, Step, was found non-efficacious. Although the vaccine did not prevent HIV-1 infection or lower viral-load set...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Hopkins, Kathryn L., Laher, Fatima, Otwombe, Kennedy, Churchyard, Gavin, Bekker, Linda-Gail, DeRosa, Stephen, Nchabeleng, Maphoshane, Mlisana, Koleka, Kublin, James, Gray, Glenda
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Public Library of Science 2014
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4121165/
https://ncbi.nlm.nih.gov/pubmed/25090110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0103446
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन